tPA in daily clinical practice

Stroke. 2003 May;34(5):1106-13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Case Management*
  • Cerebral Hemorrhage / chemically induced
  • Cerebral Hemorrhage / mortality
  • Drug Evaluation
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Health Services Accessibility
  • Hospital Mortality
  • Hospitals, Community
  • Hospitals, Special
  • Humans
  • Multicenter Studies as Topic
  • Patient Education as Topic
  • Risk
  • Safety
  • Stroke / drug therapy*
  • Stroke / mortality
  • Thrombolytic Therapy* / adverse effects
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator